New York, NY, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Healthcare Regulatory Affairs Outsourcing Market by Services (Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications and Services Registrations, Regulatory Consulting and Legal Representation, and Other Regulatory Affairs) and by End-User (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Food and Beverage Companies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024”. According to the report, global healthcare regulatory affairs outsourcing market was valued at approximately USD 3.37 billion in 2017 and is expected to generate revenue of around USD 7.26 billion by end of 2024, growing at a CAGR of around 11.60% between 2018 and 2024.
The world has become a global village wherein many companies are in a race to place their new products in the market and gain market share. In such cases, a small delay in gaining market access can lead to a huge loss in terms of revenue generation and market share. The success key to pharmaceutical companies lies in getting timely approval from the regulators. In order to obtain timely approvals, companies rely on regulatory departments to outsource the task to regulatory affairs consulting firms. With the changing customer requirements and regulatory environment, regulatory affairs work seems to be a more beneficial option in terms of both time and money. Regulatory affairs keep on updating with the current regulations and have a vital experience in the field to expedite the approval process.
Browse through 45 Tables & 26 Figures spread over 110 Pages and in-depth TOC on “Global Healthcare Regulatory Affairs Outsourcing Market Size, Share, Trends and Forecast, 2017 - 2024”.
Request Free Sample Report of Global Healthcare Regulatory Affairs Outsourcing Market Report @ https://www.zionmarketresearch.com/sample/healthcare-regulatory-affairs-outsourcing-market
The healthcare regulatory affairs outsourcing market is fragmented on the basis of services into regulatory writing and publishing, regulatory submissions, legal representation, and regulatory consulting, clinical trial applications and services registrations, and other regulatory affairs. In 2017, regulatory writing and publishing segment held the largest share of the market due to rising trends of outsourcing non-core function by pharma companies. Legal representation is likely to be the fastest growing segment owing to its rising demand in the European region which is gaining market authorization for companies. Globalization of clinical trials in the regions of the Asia Pacific and Latin America is expected to increase the demand for clinical trial application services and product registration market thus contributing to the growth of healthcare regulatory affairs outsourcing market.
Based on the end user, the market is segmented into biotechnology companies, mid-size pharmaceutical companies, medical device companies, large pharmaceutical companies, and food and beverage companies. The biotechnology companies are expected to be the fastest growing end-user segment. Factors such as increasing prevalence of a large number of viral, bacterial, and chronic diseases and patent expiration have provoked many biopharmaceutical companies to develop a large number of new products. With this rising number of products, the demand for product registration services and clinical trial applications is also substantially growing which is further boosting the market growth of healthcare regulatory affairs outsourcing.
Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/healthcare-regulatory-affairs-outsourcing-market
North America and Europe are likely to be the leading markets for healthcare regulatory affairs outsourcing market. The U.S and Canada are major countries where a maximum number of clinical trials are conducted in this region. Major clinical research organizations and biopharmaceutical companies have their hubs in this region and due to advancement in the technology, the demand for efficient supplies is increasing and these regions are anticipated to dominate the market for healthcare regulatory affairs outsourcing over the forecast period. The industry participants in Europe are considerably spending on research and development activities. Also, the region has high healthcare investments and government funding. Growth in emerging areas like orphan drugs and biosimilars are likely to encourage the demand for regulatory expertise thereby contributing to the growth of the healthcare regulatory affairs outsourcing market in these regions.
Asia Pacific is estimated to showcase the highest growth potentials in the healthcare regulatory affairs outsourcing market and is also expected to grow at the highest CAGR in comparison to other regions. Countries like Malaysia, Singapore, and India are the most attractive markets due to the advantages these countries have like the presence of skilled practitioners and availability of government support to develop outsourcing hubs; thus attracting number of biotech and pharma companies to outsource clinical trial activities to contract research organizations in this region.
Browse the full "Healthcare Regulatory Affairs Outsourcing Market by Services (Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications and Services Registrations, Regulatory Consulting and Legal Representation, and Other Regulatory Affairs) and by End-User (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Food and Beverage Companies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024" report at https://www.zionmarketresearch.com/report/healthcare-regulatory-affairs-outsourcing-market
Latin America and the Middle East and Africa are anticipated to be the most potential markets owing to the growing access to information, access to new drugs for research centers, high cancer burden, and improving patient education. Thus, all the aforementioned parameters are expected to propel the healthcare regulatory affairs outsourcing market globally.
Some of the leading players in healthcare regulatory affairs outsourcing market include Medpace, Inc., Promedica International, PARAXEL International Corporation, Covance, Inc., Freyr Solutions, Criterium, Inc., Accell Clinical Research, PRA Health Sciences, Inc., Wuxi AppTec, and Quintiles IMS Holdings, Inc. Leading players have realized that timely clinical approvals and marketing from the government bodies are key parameters in new product development. Thus, companies are focused on strengthening their in-house regulatory departments.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/healthcare-regulatory-affairs-outsourcing-market
This report segments the global healthcare regulatory affairs outsourcing market as follows:
Global Healthcare Regulatory Affairs Outsourcing Market: Services Segment Analysis
- Regulatory Writing and Publishing
- Regulatory Submissions
- Clinical Trial Applications and Services Registrations
- Regulatory Consulting and Legal Representation
- Other Regulatory Affairs
Global Healthcare Regulatory Affairs Outsourcing Market: End-User Segment Analysis
- Mid-Size Pharmaceutical Companies
- Large Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Companies
- Food and Beverage Companies
Global Healthcare Regulatory Affairs Outsourcing Market: Regional Segment Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Related Reports:
- Artificial Intelligence in Diabetes Management Market: https://www.zionmarketresearch.com/report/artificial-intelligence-in-diabetes-management-market
- Nutraceutical Excipients Market: https://www.zionmarketresearch.com/report/nutraceutical-excipients-market
- Digital Pathology Market: https://www.zionmarketresearch.com/report/digital-pathology-market
- Active Wound Care Market: https://www.zionmarketresearch.com/report/active-wound-care-market
- Forensic Technologies Market: https://www.zionmarketresearch.com/report/forensic-technologies-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Blog: http://www.intenseresearch.com | http://www.mrsresearchgroup.com | http://www.marketresearchtrade.com | https://qyresearchgroup.com | http://marketnreports.com | https://zmrnewsjournal.us | http://www.e-marketresearch.com
Contact Us:
Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com
Blog: http://zmrblog.com